Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy
Sergio Giralt(Memorial Sloan Kettering Cancer Center), Richard E. Champlin(The University of Texas MD Anderson Cancer Center), James Gajewski(The University of Texas MD Anderson Cancer Center), Gabriela Rondón(The University of Texas MD Anderson Cancer Center), Michael J. Keating(The University of Texas MD Anderson Cancer Center), Maher Albitar(Genomic Health (United States)), Miloslav Beran(The University of Texas MD Anderson Cancer Center), Issa F. Khouri(The University of Texas MD Anderson Cancer Center), Koen van Besien(University Hospitals of Cleveland), Rakesh Mehra(The University of Texas MD Anderson Cancer Center), Elihu H. Estey(University of Washington), Donna Przepiorka(The University of Texas MD Anderson Cancer Center), Paolo Anderlini(The University of Texas MD Anderson Cancer Center), Hagop M. Kantarjian(The University of Texas MD Anderson Cancer Center), Susan O’Brien(University of California, Irvine), Steve Kornblau(The University of Texas MD Anderson Cancer Center), Charles Koller(The University of Texas MD Anderson Cancer Center), David F. Claxton(The University of Texas MD Anderson Cancer Center), Martin Körbling(The University of Texas MD Anderson Cancer Center), Börje S. Andersson(The University of Texas MD Anderson Cancer Center)
Cited by 1,153
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k